Emma Verner

Dr. Emma Verner is a Clinical Senior Lecturer at the Concord Clinical School, part of the University of Sydney. She specializes in clinical oncology and hematology, focusing on hematological malignancies and their treatment.

• University: University of Sydney
• School: Concord Clinical School
• Rank: Senior Lecturer
• Email: emma.verner@sydney.edu.au

Her research centers on follicular lymphoma, chronic lymphocytic leukemia (CLL), and acute myeloid leukemia (AML), with an emphasis on clinical trials, treatment outcomes, and risk factors. She investigates dietary and environmental influences on lymphoma incidence and survival.

Dr. Verner's publications from 2021–2025 include pivotal studies on CLL therapies (e.g., zanubrutinib), AML outcomes in real-world settings, and DLBCL management guidelines. Subfields span targeted therapy, environmental epidemiology, and drug combinations.

She collaborates with the Australasian Leukaemia & Lymphoma Group (ALLG) and Australasian Lymphoma Alliance on clinical trials. No specific awards, grants, or students are mentioned in the available data.